Regenxbio RGNX Interest Income From Licencing
Interest Income From Licencing at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept rgnx:InterestIncomeFromLicencing.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's interest income from licencing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's interest income from licencing?
- Regenxbio (RGNX) reported interest income from licencing of $16K in Q1 2026.
- How has Regenxbio's interest income from licencing changed year-over-year?
- Regenxbio's interest income from licencing decreased by 36.0% year-over-year, from $25K to $16K.
- What is the long-term trend for Regenxbio's interest income from licencing?
- Over 3 years (2021 to 2025), Regenxbio's interest income from licencing has grown at a -51.3% compound annual growth rate (CAGR), from $719K to $83K.
- What does interest income from licencing mean?
- This represents interest income specifically derived from deferred payments or financing arrangements related to licensing agreements. It reflects the financial component of long-term intellectual property contracts rather than core operational revenue. This metric helps distinguish between income generated from core licensing activity versus income generated from the time-value of money in contractual arrangements.